Evidence map›Paper›PMID 20633557›Full record

ArticleExperimental neurology2010

Dynamic quantification of host Schwann cell migration into peripheral nerve allografts.

Elizabeth L Whitlock, Terence M Myckatyn, Alice Y Tong, Andrew Yee, Ying Yan, Christina K Magill, Philip J Johnson, Susan E Mackinnon

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Elizabeth L WhitlockDivision of Plastic and Reconstructive Surgery, Washington University School of Medicine, Saint Louis, MO, USA.
Terence M Myckatyn
Alice Y Tong
Andrew Yee
Ying Yan
Christina K Magill
Philip J Johnson
Susan E Mackinnon
Washington University in St. Louis · US

Funding

NERVE ALLOTRANSPLANTATION FOR TRAUMATIC NERVE INJURYR01NS033406 · NINDS · WASHINGTON UNIVERSITY · PI MACKINNON, SUSAN E · 1994 to 2011
$5.3M
Howard Hughes Medical InstituteNINDS NIH HHS 5R01NS033406NINDS NIH HHS R01 NS033406
6 · The paper itself

Abstract

Host Schwann cell (SC) migration into nerve allografts is the limiting factor in the duration of immunosuppression following peripheral nerve allotransplantation, and may be affected by different immunosuppressive regimens. Our objective was to compare SC migration patterns between clinical and experimental immunosuppression regimens both over time and at the harvest endpoint. Eighty mice that express GFP under the control of the Schwann cell specific S100 promoter were engrafted with allogeneic, nonfluorescent sciatic nerve grafts. Mice received immunosuppression with either tacrolimus (FK506), or experimental T-cell triple costimulation blockade (CSB), consisting of CTLA4-immunoglobulin fusion protein, anti-CD40 monoclonal antibody, and anti-inducible costimulator monoclonal antibody. Migration of GFP-expressing host SCs into wild-type allografts was assessed in vivo every 3 weeks until 15 weeks postoperatively, and explanted allografts were evaluated for immunohistochemical staining patterns to differentiate graft from host SCs. Immunosuppression with tacrolimus exhibited a plateau of SC migration, characterized by significant early migration (< 3 weeks) followed by a constant level of host SCs in the graft (15 weeks). At the endpoint, graft fluorescence was decreased relative to surrounding host nerve, and donor SCs persisted within the graft. CSB-treated mice displayed gradually increasing migration of host SCs into the graft, without the plateau noted in tacrolimus-treated mice, and also maintained a population of donor SCs at the 15-week endpoint. SC migration patterns are affected by immunosuppressant choice, particularly in the immediate postoperative period, and the use of a single treatment of CSB may allow for gradual population of nerve allografts with host SCs.

Indexed as

Analysis of VarianceAnimalsAntibodies, MonoclonalBlotting, WesternCaspase 3CD40 AntigensCell MovementImmunohistochemistryImmunosuppression TherapyImmunosuppressive AgentsMiceMice, TransgenicNerve RegenerationS100 ProteinsSchwann CellsSciatic NerveAntibodies, MonoclonalCaspase 3CD40 AntigensImmunosuppressive AgentsS100 ProteinsTacrolimus

Identifiers

PMID20633557
PMCPMC2956413
OpenAlexW2022756809

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.